Core Viewpoint - The skincare brand Rehyadro under Huaxi Biological has faced operational stagnation, with its online stores cleared of products, indicating a strategic shift by the company to focus on its main brands [1][5][6]. Group 1: Brand Operations - Consumers have reported that the Rehyadro flagship store is no longer available, and products such as hyaluronic acid sprays have been taken down from various online platforms [1][3]. - Rehyadro, which focuses on collagen-based skincare products, has multiple series targeting different age groups and skincare needs, including anti-wrinkle and moisturizing lines [2]. - The official flagship store on Douyin has 180,000 followers and a total sales volume of 425,000, but currently shows "products being shelved" [5]. Group 2: Company Response and Strategy - Huaxi Biological stated that Rehyadro is not a major brand for the company, and the adjustments are part of a strategy to concentrate on core businesses [1][6]. - The company has undergone significant changes, including renaming its personal health consumer goods line to "Skin Science Innovation Transformation Line" and restructuring its team and brand positioning [7][8]. Group 3: Financial Performance - Huaxi Biological's functional skincare business saw a revenue decline of 18.45% in 2023, dropping to 3.757 billion, with its share of total revenue decreasing to 61.84% [7]. - The skincare segment's revenue for the first half of the year was 2.261 billion, down 19.57%, with net profit falling 35.38% to 221 million [8]. - The company has significantly reduced brand incubation plans lacking clear technological support, aiming to strengthen the connection between technological achievements and consumer products [8].